The sepsis diagnostics market is projected to grow at a CAGR of 10% during the forecast period, according to the latest market research report. In 2022, the global market size was valued at USD 632.5 million, and it is expected to reach USD 1491.4 million by 2030. The increasing prevalence of sepsis, a potentially fatal illness caused by the body's reaction to infection, is one of the primary factors driving the market's revenue growth. According to the World Health Organization (WHO), sepsis affects 30 million people globally every year and has a death rate of 20-30%. Sepsis is also a major cause of death in Intensive Care Units (ICUs) worldwide.

To meet this demand, manufacturers are developing and releasing new diagnostic tests such as Point-Of-Care (POC) tests, molecular diagnostics, and biomarker-based assays for sepsis. These tests provide quick and accurate results, enabling early diagnosis, timely treatment, and better patient outcomes. The sepsis diagnostics market is highly competitive, with key players such as Stryker Corporation, Medtronic, and Boston Scientific Corporation leading the way.

Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.reportsanddata.com/download-free-sample/2234

Key participants include BioMérieux (France), Danaher (US), Becton, Dickinson and Company (US), Roche (Switzerland), and Abbott (US), T2 Biosystems (US), Luminex (US), Thermo Fisher Scientific (US), Bruker (US), CytoSorbents (US), and EKF (US)

  • Sepsis Diagnostics market is growing at a CAGR of 9% in Asia Pacific followed by North America and Europe with 8.7 % and 8.8% CAGR respectively. High prevalence of chronic diseases is expected to drive the market growth.
  • As of 2019, Blood Culture technology segment dominated Sepsis Diagnostics which holds 37.3% of the global market. North America regional market is the chief revenue generating source for this product segment, followed by Europe and Asia-Pacific regions.
  • The market of sepsis diagnostic is driven by the increase in sepsis cases, caused by gram-positive bacteria. The gram-positive bacterium has led to an increase in the number of patients with severe sepsis conditions and septic shock.
  • Introduction of new products for diagnostic purposes is expected to majorly drive the market for sepsis diagnosis in the coming years. For example, VIDAS B•R•A•H•M•S PCT, an automated assay measuring procalcitonin (PCT) levels launched by a leading in vitro diagnostic company, BioMérieux, enables the healthcare professions to take important decisions related to the recommendation of antibiotics for the patient

Browse Full Report Description + Research Methodology + Table of Content + Infographics@ https://www.reportsanddata.com/report-detail/sepsis-diagnostics-market

Here are some key highlights from the report:

  • Blood transfusion of infected is one of the leading causes for increase in sepsis cases. To prevent spread of sepsis through blood transfer, Becton, Dickinson and Company introduced a new product called BD BACTEC. This is a platelet quality control media, which enables the experts and healthcare professionals to effectively identify the infected platelet units.
  • Sepsis is a fatal bacterial infection that leads to blot clots and inflammation in the body slowly progressing towards multiple organ failure. Thus controlling the infection in its infant stage is very essential. To make this possible, European Union gave its approval for CytoSorb, a blood purification antibiotic that reduces the inflammation and saves the patient from the life-threatening infection.
  • The U.S. Centers for Disease Control and Prevention states that sepsis ranks 9th as the leading infection related deaths in the U.S. and also is the most expensive disease treatment in the United States.
  • Many researches have been conducted on Sepsis. Some focus on the symptoms, causes and prevention methods while the other focuses on the microbiological level. For instance, in 2016, The National Institutes of Health published a report on Vitamin C Infusion for Treatment in Sepsis Induced Acute Lung Injury (CITRIS-ALI).

Custom Requirements can be requested for this Report [Customization Available] @ https://www.reportsanddata.com/request-customization-form/2234

For the purpose of this report, Reports and Data has segmented the Sepsis Diagnostics market on the basis of product type, technology type, pathogens type, method type, test type, end use, and region:

Product Type

  • Blood Culture Media
  • Assays & Reagents
  • Instruments
  • Software
  • Others

Technology Type (Reve)

  • Microbiology
  • Molecular Diagnostics
  • Immunoassays
  • Flow Cytometry
  • Microfluidics
  • Biomarkers

Pathogens Type

  • Bacterial Sepsis
    • Gram-Positive Bacteria
    • Gram-Negative Bacteria
  • Fungal Sepsis
  • Others

Method Type

  • Conventional Diagnostic
  • Automatic Diagnostic

Test Type

  • Laboratory Tests
  • Point-of-care Tests

End Use

  • Hospital
  • Clinics
  • Others

Regional Outlook

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Spain
    • Italy
    • Rest of the Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Rest of Asia-Pacific
  • Middle East & Africa
  • Latin America
    • Brazil

Latest Research Reports Published by Reports and Data:

Blockchain in Healthcare Market by Type (Public, Private, Hybrid), Application (Clinical Data Exchange & Interoperability, Claims Adjudication & Billing Management, Drug Supply Chain Management, Clinical Trials, Others), End-use (Pharmaceutical Companies, Healthcare Providers, Healthcare Payers), By Region Forecast to 2032

Hospital Equipment and Supplies Market By Product Type (Diagnostic Equipment, Patient Monitoring Equipment, Operating Room Equipment, Mobility Aids and Transportation Equipment, Sterilization Equipment, and Others), By End-use (Hospitals, Clinics, and Others), and By Region Forecast to 2032

Ankylosing Spondylitis (AS) Market  By Type (Axial Spondyloarthritis, Non-Radiographic Axial Spondyloarthritis), By Treatment (Nonsteroidal Anti-Inflammatory Drugs, Biologics, Others), By End-User (Hospitals, Clinics, Others), and By Region Forecast to 2032

 

Influenza Diagnostics Market By Product Type [Rapid Influenza Diagnostic Tests (RIDT), Reverse Transcriptase Polymerase Chain Reaction (RT-PCR), Cell Culture, Immunofluorescence, and Others], By End-use (Hospitals, Clinical Laboratories, Research Laboratories, and Others), and By Region Forecast to 2032

 

Surgical Robot Market By Application (Orthopedics, Neurology, Urology, Gynecology, and Others), and By Region Forecast to 2032

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, TouchPoints, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provide our clients with the ability to secure an edge over their respective competitors.

Contact Us:

John W

(Head of Business Development)

Reports and Data | Web: www.reportsanddata.com

Direct Line: +1-212-710-1370

E-mail: [email protected]

Blogs | Press Release | Industry News | Our competencies

Browse More Upcoming Reports @ https://www.reportsanddata.com/upcoming-reports

Browse More Latest Reports @ https://www.reportsanddata.com/report

Read our Press Release @ https://www.reportsanddata.com/press-release/global-sepsis-diagnostics-market

Trending Titles Cocaine Intoxication Treatment Market | Behcets Syndrome Treatment Market